Avacta’s David Wilson wrote an article that was featured in the European Biopharmaceutical Review, July 2020 edition about the urgent need for the development of rapid diagnostic tests to tackle the COVID-19 pandemic.
- The article can re read in full here.
*This article is taken from European Biopharmaceutical Review July 2020, pages 8-10. © Samedan Ltd